Back to Search Start Over

Effect of Mutant and Engineered High-Acetate-Producing Saccharomyces cerevisiae var. boulardii Strains in Dextran Sodium Sulphate-Induced Colitis.

Authors :
Deleu, Sara
Jacobs, Inge
Vazquez Castellanos, Jorge F.
Verstockt, Sare
Trindade de Carvalho, Bruna
Subotić, Ana
Verstockt, Bram
Arnauts, Kaline
Deprez, Lowie
Vissers, Eva
Lenfant, Matthias
Vandermeulen, Greet
De Hertogh, Gert
Verbeke, Kristin
Matteoli, Gianluca
Huys, Geert R. B.
Thevelein, Johan M.
Raes, Jeroen
Vermeire, Séverine
Source :
Nutrients; Aug2024, Vol. 16 Issue 16, p2668, 17p
Publication Year :
2024

Abstract

Acetate-producing Saccharomyces cerevisiae var. boulardii strains could exert improved effects on ulcerative colitis, which here, was preclinically evaluated in an acute dextran sodium sulphate induced model of colitis. Nine-week-old female mice were divided into 12 groups, receiving either drinking water or 2.75% dextran sodium sulphate for 7 days, combined with a daily gavage of various treatments with different levels of acetate accumulation: sham control (phosphate buffered saline, no acetate), non-probiotic control (Baker's yeast, no acetate), probiotic control (Enterol<superscript>®</superscript>, transient acetate), and additionally several Saccharomyces cerevisiae var. boulardii strains with respectively no, high, and extra-high acetate accumulation. Disease activity was monitored daily, and feces samples were collected at different timepoints. On day 14, the mice were sacrificed, upon which blood and colonic tissue were collected for analysis. Disease activity in inflamed mice was lower when treated with the high-acetate-producing strain compared to sham and non-probiotic controls. The non-acetate-producing strain showed higher disease activity compared to the acetate-producing strains. Accordingly, higher histologic inflammation was observed in non- or transient-acetate-producing strains compared to the sham control, whereas this increase was not observed for high- and extra-high-acetate-producing strains upon induction of inflammation. These anti-inflammatory findings were confirmed by transcriptomic analysis of differentially expressed genes. Moreover, only the strain with the highest acetate production was superior in maintaining a stable gut microbial alpha-diversity upon inflammation. These findings support new possibilities for acetate-mediated management of inflammation in inflammatory bowel disease by administrating high-acetate-producing Saccharomyces cerevisae var. boulardii strains. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20726643
Volume :
16
Issue :
16
Database :
Complementary Index
Journal :
Nutrients
Publication Type :
Academic Journal
Accession number :
179355668
Full Text :
https://doi.org/10.3390/nu16162668